Clinical Trials Logo
  1. Home
  2. Pain, Neuropathic
  3. NCT00969059

Study in Neuropathic Pain Patients With Peripheral Nerve Injury — PNI  

Pain, Neuropathic Clinical Trial

Official title:
A Randomised, Double Blind Study to Evaluate the Safety and Efficacy of the p38 Kinase Inhibitor, GW856553, in Subjects With Neuropathic Pain From Peripheral Nerve Injury

Clinical Trial Summary

This study will be a double-blind, placebo-controlled, parallel group study. After enrolment and initial assessments, subjects will receive oral GW856553 7.5 milligram (mg) twice daily (BID) or matching placebo for 28 days in a 1:1 ratio. Sufficient numbers of subjects will be recruited to obtain 142 evaluable subjects. This is a double-blind, randomized, placebo-controlled, parallel group study. Subjects will undertake a screening period which may last up to approximately 3 weeks, followed by a baseline period of 1 week, a randomized treatment period of 4 weeks and a follow-up period of approximately 2 weeks. This is a multi-centre, double-blind, randomized, placebo-controlled study in subjects who have at least moderate intensity of neuropathic pain resulting from peripheral nerve injury due to trauma or surgery. It will investigate the efficacy, safety and tolerability of GW856553 over 28 days of treatment. Approximately 158 subjects will be randomized to ensure 142 evaluable subjects. Randomization ratio will be 1:1 for placebo or GW856553 respectively. The dose of GW856553 will be 7.5 mg BID.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00969059
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase Phase 2
Start date August 2009
Completion date July 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Enrolling by invitation NCT04097015 - Using NI-ES to Treat Spinal Cord Injury (SCI) N/A
Not yet recruiting NCT04585620 - Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery Phase 1/Phase 2
Completed NCT04371575 - Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients
Completed NCT03723447 - Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) Phase 4
Completed NCT01485185 - Gabapentin and Donepezil Combination on Experimental Human Pain Models Phase 1
Completed NCT04375436 - Safety and Tolerability of NTRX-07 in Healthy Volunteers Phase 1
Terminated NCT03691038 - Comparison of Conventional Dose Regimen and New Dose Regimen of Pregabalin N/A
Completed NCT03674489 - Local and Widespread Hypoalgesic Effects of Neurodynamic Mobilization in Healthy Controls N/A
Recruiting NCT04299893 - Ozone Therapy in Chemotherapy-induced Peripheral Neuropathy: RCT (O3NPIQ) Phase 2/Phase 3
Recruiting NCT03618589 - Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy Phase 1
Completed NCT04625504 - Investigating Biological Targets, Markers, and Intervention for Chronic Pain N/A
Recruiting NCT04622904 - Lidocaine and Magnesium and Ketamine in Gynecological Surgery N/A
Recruiting NCT06062108 - Prevalence of Pain in Hospitalized Cirrhotic Patients
Recruiting NCT04718116 - Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery N/A
Recruiting NCT04909593 - Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial N/A
Recruiting NCT05243940 - Opioid-free Anesthesia in Thyroidectomies N/A
Recruiting NCT05349448 - Can Dexmedetomidine With Hyalase Augment Quality and Duration of Analgesia When Added to Lumbar Epidural Steroid in Failed Back Surgery. Randomized Double Blind Study Early Phase 1